FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the chemical and pharmaceutical industry and is an anticoagulant agent of indirect action, comprising 2-oxo-3-(3-oxo-1-phenylbutyl)-2H-chromen-4-yl 2-(7-methoxy-2-oxo-2H-chromen-8-yl)-acetate as the active substance.
EFFECT: drug of the present invention has a pronounced effect on the blood coagulation system and has lower toxicity than drugs used in medical practice.
1 cl, 7 dwg, 2 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HYBRID COUMARINS WITH INDIRECT ANTICOAGULANT ACTION | 2018 |
|
RU2672062C1 |
| ANTICOAGULANT AGENT OF INDIRECT ACTION ON BASIS OF DIUMANCAL | 2018 |
|
RU2671983C9 |
| ANTIARRHYTHMIC DRUG BASED ON HYBRID MOLECULES OF AMLODIPINE WITH (7-METHOXICUMARIN-4-YL)ACETIC ACID | 2018 |
|
RU2678969C1 |
| IMMUNOMODULATORY AND ANTIVIRAL AGENT BASED ON (2-((COUMARIN-7-YL)OXY)ETHYL) 3-HYDROXY-20(29)-LUPEN-28-OATE | 2018 |
|
RU2686743C1 |
| DERIVATIVES OF 2-H-1-BENZOPYRANE-2-ONE ELICITING ANTI-CALCIUM ACTIVITY | 2003 |
|
RU2242471C1 |
| CRYSTALLINE FORM OF COCRYSTAL 4-HYDROXO-3-(3-OXO-1-PHENYLBUTYL)-2H-1-BENZOPYRAN-2-ONE WITH DIMETHYLSULPHOXIDE, A METHOD FOR PRODUCTION THEREOF AND USE AS A RODENTICIDE AGENT | 2020 |
|
RU2739772C1 |
| AGENT FOR TREATMENT OF PATIENT WITH HEART ISCHEMIC DISEASE | 1998 |
|
RU2155036C2 |
| 3-O-PROPIONATE ALLOBETULENOLE (19BETA,28-EPOXY-18ALPHA-OLEANANE-3BETA-YL AND PROPIONATE) IMMUNOMODULATORY AGENT | 2013 |
|
RU2554475C2 |
| COPOLYMERS OF N-VINYLPYRROLIDONE WITH DERIVATIVES OF 5,6-BENZO-ALPHA-PYRONE POSSESSSING ANTIGEN PROPERTIES | 0 |
|
SU1034383A1 |
| MEDICAMENT WITH PROLONGED ANTI-CALCIUM ACTIVITY IN THE FORM OF 1/10% INTRAVENOUS SOLUTION | 2004 |
|
RU2255728C1 |
